N0321: A phase I study of bortezomib, paclitaxel, carboplatin (CBDCA), and radiotherapy (RT) for locally advanced non-small cell lung cancer (NSCLC). Background: Concurrent chemoradiotherapy with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback